Avenue Net Debt vs Total Cash From Operating Activities Analysis
| ATXI Stock | USD 3.71 0.09 2.37% |
Avenue Therapeutics financial indicator trend analysis is way more than just evaluating Avenue Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Avenue Therapeutics is a good investment. Please check the relationship between Avenue Therapeutics Net Debt and its Total Cash From Operating Activities accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avenue Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Avenue Stock please use our How to Invest in Avenue Therapeutics guide.
Net Debt vs Total Cash From Operating Activities
Net Debt vs Total Cash From Operating Activities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Avenue Therapeutics Net Debt account and Total Cash From Operating Activities. At this time, the significance of the direction appears to have strong relationship.
The correlation between Avenue Therapeutics' Net Debt and Total Cash From Operating Activities is 0.66. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Total Cash From Operating Activities in the same time period over historical financial statements of Avenue Therapeutics, assuming nothing else is changed. The correlation between historical values of Avenue Therapeutics' Net Debt and Total Cash From Operating Activities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Avenue Therapeutics are associated (or correlated) with its Total Cash From Operating Activities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Cash From Operating Activities has no effect on the direction of Net Debt i.e., Avenue Therapeutics' Net Debt and Total Cash From Operating Activities go up and down completely randomly.
Correlation Coefficient | 0.66 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Total Cash From Operating Activities
Most indicators from Avenue Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Avenue Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avenue Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Avenue Stock please use our How to Invest in Avenue Therapeutics guide.As of now, Avenue Therapeutics' Issuance Of Capital Stock is increasing as compared to previous years. The Avenue Therapeutics' current Enterprise Value Over EBITDA is estimated to increase to 0.01, while Selling General Administrative is projected to decrease to under 3.3 M.
Avenue Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Avenue Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Avenue Therapeutics fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 8.9M | 3.2M | 4.0M | 6.8M | 1.9M | 1.8M | |
| Other Current Liab | 1.7M | 714K | 147K | 2.6M | 795K | 986.7K | |
| Total Current Liabilities | 2.1M | 886K | 509K | 3.6M | 1.2M | 2.2M | |
| Total Stockholder Equity | 6.8M | 2.4M | 3.5M | 3.9M | 1.6M | 2.9M | |
| Net Tangible Assets | (631K) | 6.8M | 2.4M | 3.5M | 4.0M | 2.8M | |
| Net Debt | (8.7M) | (3.1M) | (3.8M) | (6.7M) | (1.8M) | (1.9M) | |
| Retained Earnings | (68.1M) | (73.3M) | (77.0M) | (80.6M) | (90.9M) | (86.4M) | |
| Accounts Payable | 368K | 172K | 362K | 970K | 401K | 381.0K | |
| Cash | 8.7M | 3.1M | 3.8M | 6.7M | 1.8M | 1.7M | |
| Cash And Short Term Investments | 8.7M | 3.1M | 3.8M | 6.7M | 1.8M | 1.7M | |
| Common Stock Shares Outstanding | 1.0M | 1.1M | 1.1M | 2.2M | 141.2K | 134.2K | |
| Liabilities And Stockholders Equity | 8.9M | 3.2M | 4.0M | 6.8M | 1.9M | 1.8M | |
| Non Current Liabilities Total | 0.0 | 3.6M | 368K | 172K | 362K | 949.0 | |
| Capital Surpluse | 38.9M | 41.6M | 74.9M | 75.6M | 87.0M | 91.3M | |
| Other Stockholder Equity | 74.9M | 75.6M | 80.4M | 84.5M | 92.5M | 59.9M | |
| Total Liab | 2.1M | 886K | 509K | 3.6M | 1.2M | 1.1M | |
| Total Current Assets | 8.9M | 3.2M | 4.0M | 6.8M | 1.9M | 1.8M | |
| Other Assets | 1.9M | 170K | 113K | 137.0 | 67K | 63.7K | |
| Other Current Assets | 170K | 113K | 107K | 137K | 67K | 129.6K | |
| Net Invested Capital | 6.8M | 2.4M | 3.5M | 3.9M | 1.6M | 1.5M | |
| Net Working Capital | 6.8M | 2.4M | 3.5M | 3.3M | 654K | 621.3K |
Currently Active Assets on Macroaxis
When determining whether Avenue Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Avenue Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Avenue Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Avenue Therapeutics Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avenue Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Avenue Stock please use our How to Invest in Avenue Therapeutics guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for Avenue Stock analysis
When running Avenue Therapeutics' price analysis, check to measure Avenue Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avenue Therapeutics is operating at the current time. Most of Avenue Therapeutics' value examination focuses on studying past and present price action to predict the probability of Avenue Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avenue Therapeutics' price. Additionally, you may evaluate how the addition of Avenue Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is Avenue Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avenue Therapeutics. If investors know Avenue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avenue Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Earnings Share (73.50) | Return On Assets (2.09) | Return On Equity (5.35) |
The market value of Avenue Therapeutics is measured differently than its book value, which is the value of Avenue that is recorded on the company's balance sheet. Investors also form their own opinion of Avenue Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Avenue Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avenue Therapeutics' market value can be influenced by many factors that don't directly affect Avenue Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avenue Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avenue Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avenue Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.